THE CLINICAL EXPERIENCE OF CITIKOLINE USING IN TREATMENT OF ISCHEMIC STROKE
This article presents the results of follow-up of 150 patients in recovery period after ischemic stroke (the mean age - 58,7 years). According to randomization 76 patients additionally to the basic therapy received citicoline treatment and 74 patients consisted the control group. In citicoline group the neurological deficit after ischemic stroke was significantly less than in control group. Efficacy of citicoline was higher in patients with one or two stroke risk factors. There was no benefit from additional citicoline treatment in patients with three risk factors.